Undervalued Stocks Based On Cash Flows

Results

812

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

812 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MUR
zł38.70-0.1%-1.8%zł1.6bzł50.778.412.4%12.7%Real Estate Management and Development
OCFC
US$19.02-1.0%2.6%US$1.9bUS$22.080.865.1%4.2%Banks
FSECURE
€1.98-2.4%18.9%€345.2m€2.0518.319.5%2.0%Software
6990
HK$524.50-1.6%15.5%HK$124.4bHK$614.54710.944.0%n/aPharmaceuticals & Biotech
CTT
SEK 139.409.6%-38.3%SEK 1.7bn/a47.955.3%1.7%Capital Goods
SES
CA$24.05-0.5%44.3%CA$5.2bCA$24.3639.729.7%1.7%Energy
A356860
₩41,500.0019.9%173.0%₩761.3b₩54,500.0024.546.2%0.6%Tech
IES
UK£0.23-2.6%10.7%UK£129.1mUK£0.6315.860.6%n/aCapital Goods
002627
CN¥7.139.2%22.1%CN¥4.9bCN¥8.8062.138.1%0.7%Transportation
HSW
UK£1.181.3%1.3%UK£145.6mUK£1.8626.534.7%1.8%Consumer Services
BGL
AU$1.672.5%92.0%AU$2.6bAU$1.775.639.5%n/aMaterials
SWMR
US$37.05-18.0%n/aUS$450.4mUS$60.001443.4104.0%n/aCapital Goods
GIL
CA$74.35-5.6%-2.6%CA$14.0bCA$103.8048.030.8%1.9%Consumer Durables
AZN
UK£122.341.5%3.0%UK£189.8bUK£156.3824.713.7%1.9%Pharmaceuticals & Biotech
AHR
US$57.163.6%33.8%US$13.3bUS$63.673.628.0%1.7%Real Estate
BEN
€5.85-4.9%-31.5%€468.7m€7.360.681.0%3.4%Consumer Durables
RAY B
SEK 180.50-1.2%-31.9%SEK 6.1bSEK 297.5028.525.9%2.2%Healthcare
DASH
US$236.937.6%-3.5%US$101.2bUS$252.30122.136.2%n/aConsumer Services
LHV1T
€3.340.1%-5.4%€1.1b€4.401.521.1%5.1%Banks
ATYM
UK£10.5712.6%101.3%UK£1.6bUK£11.4817.320.1%0.9%Materials
TGS
NOK 130.80-4.7%70.1%NOK 25.7bNOK 149.1828.232.6%4.4%Energy
9676
HK$4.66-4.0%-53.0%HK$4.9bHK$18.509.036.9%8.0%Food, Beverage & Tobacco
SPG
DKK 492.002.5%82.9%DKK 5.8bDKK 535.0017.318.3%0.8%Materials
SYM
US$40.61-3.4%-14.9%US$24.4bUS$64.32642.555.5%n/aCapital Goods
Page 1 of 23
Undervalued Stocks Based On Cash Flows - Investing Ideas - Simply Wall St